跳至主要内容
临床试验/JPRN-jRCT2031200182
JPRN-jRCT2031200182已完成1 期

A Phase 1, Randomized, Double-blind, Placebo-controlled Single and Multiple Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of BPN14770, A Randomized, Open-label, 2-Period Crossover Study to Assess the Effect of Food on the Pharmacokinetics of BPN14770, and An Open-label, Add-on Study to Assess the Drug-Drug Interaction Between BPN14770 and Midazolam and Between BPN14770 and Donepezil Hydrochloride, in Healthy Young and/or Elderly Participants

agata Tsutae0 个研究点目标入组 112 人开始时间: 2020年11月6日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
112

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 <= 75age old(—)
性别
All

入选标准

  • 1. Healthy Japanese or Caucasian adult participants aged >= 20 to <= 55 at the time of signing the informed consent form
  • 2. Healthy Japanese elderly participants aged >= 65 to >= 75 at the time of signing the informed consent form

排除标准

  • History or presence of cardiovascular, respiratory, hepatic, renal, gastrointestinal, endocrinological, hematological, or neurological disorders capable of significantly altering the absorption, metbolism, or elimination of drugs; constituting a risk when taking the study intervention; or interfering with the interpretation of data (depending on the judgement of investigator or subinvestigator)

研究者

发起方
agata Tsutae

相似试验

A Phase 1, Single-Dose, Multiple-Dose, Food Effect... | 临床试验